This Fall, Diligent Pharma is gearing up for an exciting series of industry events across the globe. Here’s where you’ll find us:
DPharm
- September 17–18
- Philadelphia, PA
- Patty Leuchten, Founder & CEO of Diligent Pharma, and Ken Olovich, Executive Director of Procurement & Clinical Innovation at Eli Lilly, Chorus Division, will share how their successful partnership is serving as a catalyst for industry change in the area of vendor management. By harnessing Diligent’s tech-driven, centralized platform, the Chorus Division of Lilly is accelerating vendor qualification and risk management practices, streamlining processes, and speeding up clinical trial start-ups. Together, Diligent and Lilly are driving innovation that’s transforming the industry.
- Register for DPHARM
12th Annual OCT Southern California | Booth #63
• September 24–25
• San Diego, CA
• Anthea Dransfield, Head of Quality, will present an innovative approach to vendor qualification aimed at significantly reducing clinical trial start-up times. The session will highlight how embracing a risk-based, data-driven strategy can streamline vendor onboarding, strengthen compliance practices, and offer unique advantages to both Sponsors and Vendors through a centralized tech-enabled process.
• Register for OCT Southern California
Innovation Network Gathering
- October 3–4
- West Chester, PA
- Industry leaders from AbbVie, Amgen, AstraZeneca, CSL Behring, Merck, Novartis, Sanofi, and Vertex will be gathering at an executive forum at ING to explore how to drive transformative change in vendor onboarding and management. By embracing innovative, data-driven strategies, we’ll uncover new ways to streamline vendor selection, optimize vendor oversight monitoring, enhance risk management, and accelerate clinical trial timelines. This collaborative session will bring together leading Sponsor organizations to discuss cutting-edge approaches that will optimize clinical trial execution.
- Register for ING
16th OCT New England | Booth #82
• October 23–24
• Boston, MA
• Another opportunity to catch our technology showcase, where we’ll dive into our innovative approach to vendor qualification. Anthea Dransfield, Diligent’s Head of Quality will expand on the key themes introduced at OCT Southern California, offering fresh insights and strategies that will benefit Sponsors and clinical trial service Providers.
• Register for OCT New England
SCOPE Europe
- October 29–30
- Barcelona, Spain
- Join us for an insightful keynote session on the evolution of clinical trial quality, featuring leading experts who have shaped the industry’s current approach. Moderated by Patty Leuchten, Founder & CEO of Diligent Pharma, this fireside chat will bring together Coleen Glessner, Executive Vice President of Quality, Ethics and Compliance at Emergent BioSolutions, Shyard Wong, Global Head of Clinical Quality & Continuous Improvement at Sanofi, and Kristi Koontz, VP of Global Clinical Operations, Daiichi Sankyo. Together, they’ll reflect on key milestones, discuss emerging standards, and explore the future of quality in clinical trials—driving innovation and ensuring excellence across the industry. Additionally, Patty will lead a separate panel discussion with a group of clinical trial leaders to discuss and debate the impact of ICH E6 R3; including the expected challenges and opportunities of the evolving regulations.
- Register for SCOPE Europe
Join us at these events to learn how Diligent is leading the charge in optimizing vendor management and clinical trial efficiency. We look forward to connecting with you!
Questions? Let’s chat.
Schedule a one-on-one with our team to learn more about how Diligent can support your unique qualification and risk management needs.